Proportion of isolates with decreased susceptibility or resistance in Netherlands
Netherlands: Proportion of isolates with decreased susceptibility or resistance was 0 in 2018. ◆ Volatile
Proportion of isolates with decreased susceptibility or resistance in Netherlands, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
Netherlands recorded 0 for proportion of isolates with decreased susceptibility or resistance in 2018. That is the lowest value across all 10 years on record.
Over the whole period, proportion of isolates with decreased susceptibility or resistance in Netherlands peaked at 3.26 in 2010 and was at its lowest, 0, in 2009.
That places Netherlands 25th out of 51 countries with data for 2018, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with decreased susceptibility or resistance in Netherlands, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0 | — |
| 2010 | 3.26 | — |
| 2011 | 0 | -100.0% |
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 2.2 | — |
| 2015 | 0 | -100.0% |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | 1 |
| 2010s | 0.6065 | 0 | 3.26 | 9 |
Countries ranked near Netherlands
- 22 New Zealand 0.4386 compare
- 23 United States of America 0.2907 compare
- 24 Australia 0.0666 compare
- 25 Cuba 0
- 25 Norway 0 compare
- 25 Slovakia 0 compare
- 25 France 0 compare
- 25 Colombia 0
- 25 Paraguay 0
- 25 Malta 0 compare
- 25 South Africa 0
- 25 Slovenia 0 compare
- 25 Argentina 0 compare
- 25 Côte d'Ivoire 0
- 25 Russian Federation 0
- 25 Bhutan 0 compare
- 25 Portugal 0 compare
- 25 Estonia 0
- 25 Dominican Republic 0
- 25 Latvia 0 compare
- 25 Pakistan 0 compare
- 25 Peru 0 compare
- 25 Chile 0
- 25 Iceland 0
- 25 Denmark 0 compare
- 25 Panama 0
- 25 Ireland 0 compare
- 25 Sri Lanka 0
- 25 Korea 0 compare
More health data for Netherlands
- Un projection of annual infant deaths, annual growth rate -2.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1866 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0241 units per person (2025)
- Population ages 05-09, male, annual growth rate 0.1393 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0253 units per person (2025)
- Population ages 10-14, female, annual growth rate -0.8961 % change on previous year (2025)
Frequently asked questions
- What is proportion of isolates with decreased susceptibility or resistance in Netherlands?
- Proportion of isolates with decreased susceptibility or resistance in Netherlands was 0 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Netherlands?
- The highest recorded value was 3.26 in 2010.
- What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Netherlands?
- The lowest recorded value was 0 in 2009.
- How does Netherlands rank for proportion of isolates with decreased susceptibility or resistance?
- Netherlands ranks 25th out of 51 countries with data for 2018.
- Where does this Netherlands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).